In equities, shares of Bellicum Pharmaceuticals ( BLCM ) were 10.8% higher pre-bell after the drug maker reported low rates of cancer recurrence in acute myeloid leukemia patients with its BPX-501 treatment. US stock futures moved higher on Tuesday as traders awaited for the release of the latest US inflation data. Oil prices were little changed with global benchmark Brent crude down 0.06%, while US West Texas Intermediate was up 0.02% recently after the US Energy Information Administration signaled a huge rise in production from US shale formations.